FI102613B1 - Menetelmä NMDA-antagonistien valmistamiseksi - Google Patents
Menetelmä NMDA-antagonistien valmistamiseksiInfo
- Publication number
- FI102613B1 FI102613B1 FI904588A FI904588A FI102613B1 FI 102613 B1 FI102613 B1 FI 102613B1 FI 904588 A FI904588 A FI 904588A FI 904588 A FI904588 A FI 904588A FI 102613 B1 FI102613 B1 FI 102613B1
- Authority
- FI
- Finland
- Prior art keywords
- preparation
- nmda antagonists
- nmda
- antagonists
- Prior art date
Links
- HOKKHZGPKSLGJE-GSVOUGTGSA-N N-Methyl-D-aspartic acid Chemical compound CN[C@@H](C(O)=O)CC(O)=O HOKKHZGPKSLGJE-GSVOUGTGSA-N 0.000 title 1
- 239000005557 antagonist Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6527—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
- C07F9/653—Five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
- C07F9/3808—Acyclic saturated acids which can have further substituents on alkyl
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6509—Six-membered rings
- C07F9/650952—Six-membered rings having the nitrogen atoms in the positions 1 and 4
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40947889A | 1989-09-19 | 1989-09-19 | |
| US40947889 | 1989-09-19 | ||
| US50833390A | 1990-04-11 | 1990-04-11 | |
| US50833390 | 1990-04-11 | ||
| US07/553,431 US5095009A (en) | 1990-04-11 | 1990-07-20 | NMDA antagonists |
| US55343190 | 1990-07-20 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI904588A0 FI904588A0 (fi) | 1990-09-18 |
| FI102613B FI102613B (fi) | 1999-01-15 |
| FI102613B1 true FI102613B1 (fi) | 1999-01-15 |
Family
ID=27410806
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI904588A FI102613B1 (fi) | 1989-09-19 | 1990-09-18 | Menetelmä NMDA-antagonistien valmistamiseksi |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP0418863B1 (da) |
| JP (1) | JP2934295B2 (da) |
| KR (2) | KR100191116B1 (da) |
| CN (1) | CN1027694C (da) |
| AR (2) | AR247889A1 (da) |
| AT (1) | ATE116653T1 (da) |
| AU (1) | AU632362B2 (da) |
| CA (1) | CA2025326C (da) |
| DE (1) | DE69015745T2 (da) |
| DK (1) | DK0418863T3 (da) |
| ES (1) | ES2069644T3 (da) |
| FI (1) | FI102613B1 (da) |
| GR (1) | GR3015656T3 (da) |
| HU (1) | HU207523B (da) |
| IE (1) | IE65118B1 (da) |
| IL (1) | IL95718A (da) |
| MX (1) | MX9203696A (da) |
| NO (1) | NO178375C (da) |
| NZ (1) | NZ235322A (da) |
| PT (1) | PT95344B (da) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU667845B2 (en) * | 1991-11-15 | 1996-04-18 | Merrell Dow Pharmaceuticals Inc. | N-trityl aspartic acid derivatives for preparing phosphonate NMDA antagonists |
| US5554773A (en) * | 1991-11-15 | 1996-09-10 | Merrell Pharmaceuticals Inc. | N-trityl protected aspartic acid derivatives for the preparation of phosphonate NMDA antagonists |
| GB9325368D0 (en) * | 1993-12-10 | 1994-02-16 | Univ Bristol | Organic compounds |
| EP0684238A3 (en) * | 1994-04-27 | 1997-01-15 | Hoffmann La Roche | Process for the preparation of dicarboxamides. |
| EP3427729A1 (en) | 2017-07-13 | 2019-01-16 | Paris Sciences et Lettres - Quartier Latin | Probenecid for use in treating epileptic diseases, disorders or conditions |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3970684A (en) * | 1973-07-06 | 1976-07-20 | Syntex (U.S.A.) Inc. | Polyunsaturated prostaglandin derivatives |
| CA1248531A (en) * | 1984-04-17 | 1989-01-10 | Jeffrey C. Watkins | 4-substituted piperazine-2-carboxylic acids |
-
1990
- 1990-09-13 CA CA002025326A patent/CA2025326C/en not_active Expired - Fee Related
- 1990-09-13 AU AU62474/90A patent/AU632362B2/en not_active Ceased
- 1990-09-14 NZ NZ235322A patent/NZ235322A/en unknown
- 1990-09-17 IL IL95718A patent/IL95718A/en not_active IP Right Cessation
- 1990-09-18 KR KR1019900014729A patent/KR100191116B1/ko not_active IP Right Cessation
- 1990-09-18 IE IE338090A patent/IE65118B1/en not_active IP Right Cessation
- 1990-09-18 HU HU905945A patent/HU207523B/hu not_active IP Right Cessation
- 1990-09-18 PT PT95344A patent/PT95344B/pt not_active IP Right Cessation
- 1990-09-18 FI FI904588A patent/FI102613B1/fi not_active IP Right Cessation
- 1990-09-18 NO NO904061A patent/NO178375C/no not_active IP Right Cessation
- 1990-09-19 CN CN90104580A patent/CN1027694C/zh not_active Expired - Fee Related
- 1990-09-19 DE DE69015745T patent/DE69015745T2/de not_active Expired - Fee Related
- 1990-09-19 ES ES90118033T patent/ES2069644T3/es not_active Expired - Lifetime
- 1990-09-19 EP EP90118033A patent/EP0418863B1/en not_active Expired - Lifetime
- 1990-09-19 AR AR90317901A patent/AR247889A1/es active
- 1990-09-19 JP JP2247635A patent/JP2934295B2/ja not_active Expired - Lifetime
- 1990-09-19 DK DK90118033.1T patent/DK0418863T3/da active
- 1990-09-19 AT AT90118033T patent/ATE116653T1/de not_active IP Right Cessation
-
1991
- 1991-01-25 AR AR91318918A patent/AR248028A1/es active
-
1992
- 1992-06-29 MX MX9203696A patent/MX9203696A/es unknown
-
1995
- 1995-04-03 GR GR950400800T patent/GR3015656T3/el unknown
-
1998
- 1998-09-29 KR KR1019980040434A patent/KR100196265B1/ko not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT87508A (pt) | A process for the preparation of highly soluble clear polyimides | |
| PT93785A (pt) | Processo para a preparacao de derivados de 3-substituido-2-oxindole | |
| DK0429760T3 (da) | Fremgangsmåde til fremstilling af et aromatiseringsmiddel | |
| ZA906536B (en) | Process for the preparation of a polyefin | |
| FI92403B (fi) | Menetelmä Cefodizim-dinatriumin valmistamiseksi | |
| NO901232L (no) | Fremgangsmaate for fremstilling av et farmasoeytisk preparat | |
| PT93629A (pt) | Processo para a preparacao de derivados de tieno-triazolo-diazepina | |
| BR9001503A (pt) | Processo para a preparacao de alquil-halogenossilanos | |
| IS3589A7 (is) | Aðferð við framleiðslu á efnasambandinu Indenoindoles I | |
| NO903513L (no) | Fremgangsmaate for fremstilling av cykliske neurokinin a-antagonister. | |
| FI102613B1 (fi) | Menetelmä NMDA-antagonistien valmistamiseksi | |
| PT93631A (pt) | Processo para a preparacao de derivados de tieno-triazolo-diazepina | |
| FI97542B (fi) | Uusi menetelmä 9-amino-1,2,3,4-tetrahydroakridiinien valmistamiseksi | |
| FI901358A0 (fi) | Menetelmä fluorifenolien valmistamiseksi | |
| FI91069B (fi) | Menetelmä 5-C-hydroksimetyylialdoheksoosipohjaisten yhdisteiden valmistamiseksi | |
| FI93363C (fi) | Uusi menetelmä 2-diatso-3-trisubstituoitujen silyylioksi-3-butenoaattien valmistamiseksi | |
| NO902460L (no) | Fremgangsmaate for fremstilling av en natriumpolyacrylatgel | |
| GB9027816D0 (en) | Process for the preparation of a novel intermediate | |
| BR9000119A (pt) | Processo para a preparacao de anilinofumarato | |
| ZA907310B (en) | Nmda antagonists | |
| PH25815A (en) | A process for the preparation of aluminoxanes | |
| EE9900257A (et) | Protsess NMDA antagonistide valmistamiseks | |
| FI102166B1 (fi) | Menetelmä N,N-dimetyyliaminometyyliaryyliyhdisteiden valmistamiseksi | |
| TH7144EX (th) | กรรมวิธีสำหรับเตรียม n-ซัลโฟนิล ยูเรีย | |
| NO963876D0 (no) | Fremgangsmåte for fremstilling av polypeptider |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Patent granted |
Owner name: MERRELL DOW PHARMACEUTICALS INC. |
|
| MM | Patent lapsed |
Owner name: MERRELL DOW PHARMACEUTICALS INC. |